Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

The presence of prostate cancer may be indicated by symptoms, physical examination, prostate-specific antigen (PSA), or biopsy. The PSA test increases cancer detection but does not decrease mortality.

The study suggests that doctors may need to rethink current screening ... Inherited Gene Elevates Prostate Cancer Risk in Affected Families Jan. 28, 2025 — The inherited mutated gene WNT9B ...

Prostate cancer has become England’s most common ... referred to as a PSA test. Physical exams and biopsies can also help to confirm a diagnosis. At-risk groups include over 55s, members of ...

Prostate cancer has become England’s most common cancer, according to new analysis. Diagnoses of the disease overtook breast ...

Learn how early detection of prostate cancer through screening and symptoms awareness leads to better outcomes.

Hoy is advocating for men to ask for the prostate-specific antigen (PSA) blood test, which can help diagnose prostate problems, including cancer. A physical prostate exam is also commonly used to help ...

GBMC's Sandra & Malcolm Berman Cancer Institute is a state of the art facility that brings together the oncology teams to ...

Diagnoses of prostate cancer overtook breast cancer in 2022 and 2023, according to the charity Prostate Cancer UK.

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate Cancer UK warns many will be symptomless ...